NHS won’t get cutting-edge drugs unless it pays more, says AstraZeneca boss
Pascal Soriot says cost-effectiveness thresholds for new medicines have not changed for two decadesBusiness live – latest updatesThe boss of AstraZeneca has said that unless the UK ramps up spending on new drugs, it could be on a trajectory to only bei…